To Top

Our Mission

WE ARE COMMITTED TO THE DEVELOPMENT OF FIRST-IN-CLASS, EFFECTIVE THERAPIES THAT HARNESS THE POWER OF THE TUMOR MICROENVIRONMENT (TME) TO OVERCOME DRUG RESISTANCE AND IMPROVE TREATMENT OUTCOMES FOR CANCER PATIENTS

Our Pipeline

IM1240 IM1305 CM24 NT219
Skip to content